SPRO Spero Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$1,19
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,0852-Wochen-Tief
$3,0852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$69M
P/E (TTM)
8.5
EPS (TTM)
$0.14
Umsatz (TTM)
$47M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
HOLD
Kursziel
$5
P/E
8.5
ROE
19.2%
Nettogewinnmarge
15.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SPRO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.19
Marktkapitalisierung (MRQ)
$69M
P/E (TTM)
8.5
EPS (TTM)
$0.14
Umsatz (TTM)
$47M
ROE (TTM)
19.2%
52W-Spanne
$1–$3
SPRO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$67M2016-12-31 → 2025-12-31
EPS$0.152021-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2019-12-31
Nettogewinnmarge15.7%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SPRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 8.55-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · | |
| P/S (TTM) | 1.55-Jahres-Durchschnitt ≈6.8 | ≈6.8 | 118.2 | Unterbewertet | |
| K/B (MRQ) | 1.65-Jahres-Durchschnitt ≈2.2 | ≈2.2 | 1.7 | Überbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -5.35-Jahres-Durchschnitt ≈-7.0 | ≈-7.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.15-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SPRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 12.8%5-Jahres-Durchschnitt ≈-136.7% | ≈-136.7% | -2921.7% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | 9.4%5-Jahres-Durchschnitt ≈-135.6% | ≈-135.6% | -2921.7% | Im Einklang | |
| Pretax Margin (Vorgewinnmarge) | 13.2%5-Jahres-Durchschnitt ≈-136.7% | ≈-136.7% | -169.2% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 15.7%5-Jahres-Durchschnitt ≈-137.3% | ≈-137.3% | -2791.9% | Im Einklang | |
| ROA (TTM) | 12.9%5-Jahres-Durchschnitt ≈-21.8% | ≈-21.8% | -44.8% | Spitzenklasse | |
| ROE (TTM) | 19.2%5-Jahres-Durchschnitt ≈-50.2% | ≈-50.2% | -49.6% | Spitzenklasse | |
| ROIC | 10.4%5-Jahres-Durchschnitt ≈-57.2% | ≈-57.2% | -37.6% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SPRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 6.15-Jahres-Durchschnitt ≈5.4 | ≈5.4 | 5.2 | Starke Liquidität | |
| Quick Ratio | 4.55-Jahres-Durchschnitt ≈4.1 | ≈4.1 | 5.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | SPRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 39.2%5-Jahres-Durchschnitt ≈73.6% | ≈73.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 7.7%5-Jahres-Durchschnitt ≈56.3% | ≈56.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 48.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SPRO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.75-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.7M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
81.9%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.16 | $-0.17 | 7.7% |
| 31. März 2026 | Mai 13, 2026 | $-0.13 | $-0.18 | 29.2% |
| 31. Dezember 2025 | $0.53 | $-0.20 | 359.8% | |
| 30. September 2025 | $-0.13 | $-0.26 | 49.0% | |
| 30. Juni 2025 | $-0.03 | $-0.39 | 92.3% | |
| 31. März 2025 | $-0.25 | $-0.56 | 55.4% | |
| 31. Dezember 2024 | $-0.38 | $-0.32 | -20.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | $335.0K | |
| R&D Expense | $38M | $97M | $51M | $48M | $65M | $67M | $66M | $34M | $33M | $26M | |
| SG&A Expense | $21M | $24M | $26M | $36M | $42M | $21M | $16M | $13M | $11M | $7M | |
| Operating Expenses | $60M | $121M | $82M | $96M | $106M | $88M | $81M | $47M | $44M | $34M | |
| Operating Income | $6M | $-73M | $21M | $-42M | $-88M | $-79M | $-63M | $-43M | $-42M | $-33M | |
| Interest Income | $3M | $5M | $4M | $1M | $346.0K | $401.0K | $1M | $1M | · | · | |
| Other Non-op | $7.0K | $60.0K | $-14.0K | $-55.0K | $-395.0K | $432.0K | $740.0K | $43.0K | $2M | $580.0K | |
| Pretax Income | $9M | $-69M | $25M | $-46M | $-90M | $-78M | $-61M | $-42M | $-40M | $-33M | |
| Income Tax | $261.0K | $0 | $3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | $-25M | |
| EPS (Basic) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| EPS (Diluted) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| Shares (Basic) | 56,020,363 | 54,037,917 | 52,703,467 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| Shares (Diluted) | 59,039,225 | 54,037,917 | 52,989,030 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| EBITDA | $6M | $-73M | $22M | $-41M | $-87M | · | $-62M | $-42M | $-41M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $53M | $76M | $109M | $113M | $85M | $30M | $34M | $87M | $10M | |
| Short-term Investments | · | · | · | $0 | $34M | $42M | $52M | $81M | · | · | |
| Prepaid Expense | $2M | $2M | $4M | $3M | $9M | $6M | $5M | $7M | $2M | $1M | |
| Other Current Assets | $28.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $67M | $107M | $131M | $114M | $158M | $139M | $95M | $124M | $92M | $12M | |
| PP&E (Net) | · | $0 | $2.0K | $368.0K | $1M | $2M | $2M | $3M | $1M | $2M | |
| PP&E (Gross) | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | |
| Accum. Depreciation | · | $4M | $4M | $3M | $3M | $2M | $2M | $827.0K | $643.0K | $290.0K | |
| Other Non-current Assets | $153.0K | $153.0K | $435.0K | $6M | $6M | $5M | $4M | $2M | · | · | |
| Total Assets | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Accounts Payable | $693.0K | $7M | $1M | $617.0K | $1M | $1M | $4M | $4M | $3M | $1M | |
| Current Liabilities | $9M | $49M | $37M | $22M | $19M | $14M | $27M | $12M | $8M | $7M | |
| Capital Leases | $939.0K | $3M | $4M | $5M | $6M | $7M | $5M | · | · | · | |
| Total Liabilities | $10M | $64M | $75M | $49M | $83M | $21M | $32M | $13M | $9M | $7M | |
| Common Stock | $56.0K | $55.0K | $53.0K | $52.0K | $32.0K | $29.0K | $19.0K | $17.0K | $14.0K | $0 | |
| Paid-in Capital | · | · | · | · | · | · | · | $254M | $181M | $0 | |
| Retained Earnings | $-451M | $-460M | $-391M | $-414M | $-367M | $-278M | $-199M | $-139M | $-97M | $-45M | |
| AOCI | · | · | $0 | $0 | $-2.0K | $-7.0K | $16.0K | $-28.0K | · | · | |
| Stockholders' Equity | $59M | $46M | $107M | $76M | $88M | $132M | $75M | $116M | $85M | $-45M | |
| Liabilities + Equity | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Shares Outstanding | 56,414,657 | 54,593,527 | 52,999,680 | 52,456,195 | 32,393,738 | 29,260,247 | 19,190,695 | 17,205,962 | 14,369,182 | 0 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $2.0K | $367.0K | $869.0K | $646.0K | $761.0K | $750.0K | $409.0K | $363.0K | $279.0K | |
| Stock-based Comp | $4M | $8M | $8M | $9M | $9M | $5M | $4M | $3M | $1M | $180.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Restructuring | $258.0K | $877.0K | $0 | $12M | $0 | · | · | · | · | · | |
| Other Non-cash | $-26M | $37M | $-64M | $29M | $15M | · | $6M | $-1M | $-2M | · | |
| Operating Cash Flow | $-13M | $-23M | $-33M | $-8M | $-64M | $-86M | $-50M | $-40M | $-39M | $-29M | |
| CapEx | · | · | · | · | · | $157.0K | $314.0K | $2M | $27.0K | $830.0K | |
| Investing Cash Flow | · | · | $0 | $34M | $8M | $10M | $30M | $-83M | $-27.0K | $-830.0K | |
| Stock Issued | · | $0 | $221.0K | · | $8M | $13M | $16M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | $8M | · | $16M | · | · | · | |
| Financing Cash Flow | · | $0 | $221.0K | $-30M | $84M | $131M | $16M | $70M | $116M | $34M | |
| Net Change in Cash | $-13M | $-23M | $-33M | $-3M | $27M | $55M | $-4M | $-53M | $77M | $5M | |
| Free Cash Flow | · | · | · | · | · | · | $-50M | $-42M | $-39M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% | · | -348.4% | -1079.3% | · | · | |
| Net Margin | 12.8% | -142.9% | 22.0% | -86.7% | -491.9% | · | -335.6% | -1050.5% | · | · | |
| Pretax Margin | 13.2% | -142.9% | 24.5% | -86.7% | -491.7% | · | -335.7% | -1050.5% | · | · | |
| EBITDA Margin | 9.4% | -152.9% | 21.1% | -77.2% | -478.3% | · | -344.2% | -1069.0% | · | · | |
| ROA | 9.6% | -46.8% | 14.8% | -31.4% | -55.3% | · | -51.8% | -37.5% | -72.2% | · | |
| ROE | 18.7% | -122.8% | 28.4% | -85.6% | -89.7% | · | -64.1% | -41.6% | -197.9% | · | |
| ROIC | 10.4% | -159.1% | 18.0% | -55.6% | -99.6% | · | -84.8% | -37.1% | -49.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 | · | 3.6 | 10.1 | 11.3 | · | |
| Quick Ratio | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 | · | 3.1 | 9.4 | 10.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.3 | 0.7 | 0.4 | 0.1 | · | 0.2 | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.05 | $0.84 | $2.02 | $1.45 | $2.73 | · | $3.89 | $6.71 | $5.89 | · | |
| Revenue / Share | $1.13 | $0.89 | $1.96 | $1.42 | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.21 | $-0.43 | $-0.62 | $-0.21 | · | · | · | · | · | · | |
| Cash / Share | $0.71 | $0.97 | $1.44 | $2.08 | $3.48 | · | $1.55 | $1.98 | $6.07 | · | |
| EPS (TTM) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 39.2% | -53.8% | 94.0% | 193.1% | 95.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.7% | 38.0% | 123.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.2% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | · | |
| Net Income TTM | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | · | |
| Market Cap | $131M | $56M | $78M | $91M | $519M | · | $185M | $106M | $169M | · | |
| P/E | 15.5 | -0.8 | 3.4 | -1.4 | -5.5 | · | · | · | · | · | |
| P/S | 2.0 | 1.2 | 0.8 | 1.7 | 28.4 | · | 10.2 | 26.7 | 85.3 | · | |
| P/B | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | · | 2.5 | 0.9 | 2.0 | · | |
| P / Tangible Book | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | 4.3 | · | · | · | · | |
| P / Cash Flow | -10.4 | -2.4 | -2.4 | -11.7 | -8.1 | · | -3.7 | -2.7 | -4.3 | · | |
| P / FCF | · | · | · | · | · | · | -3.7 | -2.5 | -4.3 | · | |
| Earnings Yield | 6.4% | -123.3% | 29.2% | -71.1% | -18.2% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $258.0K | $41M | $5M | $14M | $6M | $15M | $13M | $10M | $9M | $74M | $25M | $3M | $2M | $47M | $2M | |
| R&D Expense | $3M | $3M | $6M | $9M | $11M | $14M | $29M | $27M | $24M | $17M | $17M | $16M | $10M | $9M | $15M | $7M | |
| SG&A Expense | $6M | $5M | $4M | $4M | $6M | $7M | $7M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | $6M | $7M | |
| Operating Expenses | $10M | $8M | $10M | $13M | $17M | $21M | $37M | $32M | $29M | $23M | $23M | $27M | $16M | $16M | $22M | $14M | |
| Operating Income | $-10M | $-8M | $31M | $-8M | $-2M | $-15M | $-22M | $-19M | $-19M | $-14M | $51M | $-2M | $-13M | $-14M | $26M | $-12M | |
| Interest Income | $377.0K | $336.0K | $376.0K | $532.0K | $740.0K | $864.0K | $1M | $1M | $1M | $1M | $1M | $950.0K | $982.0K | $963.0K | $715.0K | $208.0K | |
| Other Non-op | $-3.0K | $-1.0K | $0 | $2.0K | $4.0K | $1.0K | $99.0K | $-26.0K | $1.0K | $-14.0K | $4.0K | $-10.0K | $-6.0K | $-2.0K | $-9.0K | $-23.0K | |
| Income Tax | · | · | $261.0K | $0 | · | · | $-290.0K | $290.0K | · | · | $387.0K | $2M | · | · | $0 | $0 | |
| Net Income | $-10M | $-7M | $32M | $-7M | $-2M | $-14M | $-21M | $-17M | $-18M | $-13M | $51M | $-3M | $-12M | $-13M | $27M | $-12M | |
| EPS (Basic) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| EPS (Diluted) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| Shares (Basic) | 57,968,608 | 57,281,570 | · | 56,280,844 | 56,026,767 | 55,376,188 | · | 54,124,862 | 53,957,766 | 53,524,037 | · | 52,710,280 | 52,571,813 | 52,527,018 | · | 35,882,076 | |
| Shares (Diluted) | 57,968,608 | 57,281,570 | · | 56,280,844 | 56,026,767 | 55,376,188 | · | 54,124,862 | 53,957,766 | 53,524,037 | · | 52,710,280 | 52,571,813 | 52,527,018 | · | 35,882,076 | |
| EBITDA | $-10M | $-8M | · | $-8M | $-2M | $-15M | · | $-19M | $-19M | $-14M | · | $-2M | $-13M | $-14M | · | $-12M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $56M | $40M | $49M | $31M | $49M | $53M | $76M | $64M | $82M | $76M | $94M | $78M | $96M | $109M | $50M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $785.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $9M | $4M | $3M | $1M | |
| Other Current Assets | $25.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $52M | $58M | $67M | $52M | $59M | $75M | $107M | $132M | $122M | $140M | $131M | $102M | $88M | $102M | $114M | $53M | |
| PP&E (Net) | · | · | · | · | · | · | · | $0 | $0 | $2.0K | $2.0K | $41.0K | $148.0K | $256.0K | $368.0K | $494.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $4M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $3M | · | |
| Other Non-current Assets | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $434.0K | $434.0K | $435.0K | $434.0K | $6M | $6M | $6M | $6M | |
| Total Assets | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Accounts Payable | $155.0K | $217.0K | $693.0K | $1M | $780.0K | $2M | $7M | $6M | $3M | $3M | $1M | $1M | $1M | $583.0K | $617.0K | $3M | |
| Current Liabilities | $8M | $5M | $9M | $14M | $15M | $29M | $49M | $49M | $46M | $42M | $37M | $25M | $17M | $23M | $22M | $16M | |
| Capital Leases | $43.0K | $507.0K | $939.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Total Liabilities | $9M | $6M | $10M | $28M | $29M | $44M | $64M | $70M | $69M | $71M | $75M | $53M | $44M | $48M | $49M | $32M | |
| Common Stock | $58.0K | $58.0K | $56.0K | $56.0K | $56.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $53.0K | $52.0K | $43.0K | |
| Retained Earnings | $-468M | $-458M | $-451M | $-483M | $-475M | $-474M | $-460M | $-439M | $-422M | $-404M | $-391M | $-442M | $-439M | $-427M | $-414M | $-441M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $44M | $53M | $59M | $26M | $33M | $34M | $46M | $66M | $80M | $96M | $107M | $54M | $55M | $65M | $76M | $32M | |
| Liabilities + Equity | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Shares Outstanding | 58,146,910 | 57,891,493 | 56,414,657 | 56,311,795 | 56,187,308 | 55,900,641 | 54,593,527 | 54,314,415 | 54,009,139 | 53,869,139 | 52,999,680 | 52,999,317 | 52,571,813 | 52,571,813 | 52,456,195 | 42,856,623 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | · | · | $0 | $0 | $2.0K | $0 | $38.0K | $108.0K | $108.0K | $113.0K | $129.0K | $257.0K | |
| Stock-based Comp | $822.0K | $1M | $1M | $1M | $714.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | $0 | $0 | $0 | $0 | $83.0K | $175.0K | $877.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-67.0K | $-152.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $17M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $44M | $-957.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-129.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | · | $6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | $14M | $6M | |
| Net Change in Cash | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $59M | $5M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -687.6% | · | -589.9% | |
| Net Margin | · | -2791.9% | · | -135.7% | -12.0% | -236.1% | · | -127.3% | -175.5% | -137.1% | · | -12.6% | -438.1% | -642.8% | · | -583.2% | |
| EBITDA Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -682.2% | · | -589.9% | |
| ROA | -16.6% | -10.5% | · | -7.8% | -1.6% | -11.3% | · | -14.2% | -14.4% | -9.1% | · | -3.7% | -14.6% | -10.3% | · | -11.2% | |
| ROE | -24.8% | -16.6% | · | -16.1% | -3.0% | -21.3% | · | -28.8% | -26.5% | -15.8% | · | -7.4% | -26.2% | -20.9% | · | -16.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 10.5 | · | 3.8 | 4.0 | 2.6 | · | 2.7 | 2.7 | 3.4 | · | 4.0 | 5.1 | 4.4 | · | 3.3 | |
| Quick Ratio | 6.0 | 10.2 | · | 3.6 | 2.1 | 1.7 | · | 1.6 | 1.4 | 2.0 | · | 3.7 | 4.5 | 4.2 | · | 3.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.3 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.76 | $0.91 | · | $0.47 | $0.58 | $0.60 | · | $1.21 | $1.49 | $1.79 | · | $1.01 | $1.04 | $1.23 | · | $0.76 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.10 | $0.25 | $0.11 | · | $0.25 | $0.19 | $0.17 | · | $0.48 | $0.05 | $0.04 | · | $0.06 | |
| Cash Flow / Share | · | $0.28 | · | · | · | $-0.07 | · | · | · | $0.11 | · | · | · | $-0.24 | · | · | |
| Cash / Share | $0.87 | $0.97 | · | $0.86 | $0.56 | $0.87 | · | $1.40 | $1.18 | $1.53 | · | $1.77 | $1.48 | $1.83 | · | $1.18 | |
| EPS (TTM) | $0.14 | $0.27 | · | $-0.79 | $-0.98 | $-1.28 | · | $0.08 | $0.34 | $0.44 | · | $0.44 | $0.17 | $-0.47 | · | $-3.13 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $47M | $61M | · | $41M | $49M | $45M | · | $106M | $118M | $111M | · | $78M | $54M | $54M | · | $9M | |
| Net Income TTM | $7M | $15M | · | $-44M | $-54M | $-70M | · | $4M | $17M | $23M | · | $-2M | $-10M | $-27M | · | $-102M | |
| Market Cap | $129M | $135M | · | $106M | $163M | $40M | · | $73M | $70M | $93M | · | $64M | $76M | $76M | · | $86M | |
| P/E | 15.8 | 8.7 | · | -2.4 | -3.0 | -0.6 | · | 16.8 | 3.8 | 3.9 | · | 2.8 | 8.5 | -3.1 | · | -0.6 | |
| P/S | 2.7 | 2.2 | · | 2.6 | 3.4 | 0.9 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | 1.4 | 1.4 | · | 9.7 | |
| P/B | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Tangible Book | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | 8.5 | · | · | · | -10.1 | · | · | · | 15.6 | · | · | · | -5.9 | · | · | |
| Earnings Yield | 6.3% | 11.5% | · | -42.0% | -33.8% | -177.8% | · | 6.0% | 26.2% | 25.6% | · | 36.4% | 11.7% | -32.4% | · | -156.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $67M | $48M | $104M | $54M | $18M |
| Betriebsgewinnmarge % | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% |
| Nettoergebnis | $9M | $-69M | $23M | $-46M | $-90M |
| Verwässerte EPS | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 |
| Quick Ratio | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 67 Einreicher · $52.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
67
Gehaltener Wert
$52.7M
Neue Positionen
23
Geschlossene Positionen
11
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (+12 vs. Vorquartal) | 11 (-1 vs. Vorquartal) | 17 (+6 vs. Vorquartal) | 8 (-5 vs. Vorquartal) | +864K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| GSK plc | $20.311.239 | 9.190.606 | 38,57% | Aktien |
| Pfizer Inc | $5.338.906 | 2.362.348 | 10,14% | Aktien |
| VANGUARD GROUP INC | $4.854.466 | 2.083.462 | 9,22% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.500.059 | 2.036.226 | 8,54% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.094.868 | 947.904 | 3,98% | Aktien |
| Alphabet Inc. | $1.966.854 | 889.979 | 3,73% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.678.031 | 759.290 | 3,19% | Aktien |
| BlackRock, Inc. | $1.313.634 | 594.404 | 2,49% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.252.145 | 566.329 | 2,38% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.152.968 | 521.705 | 2,19% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $846.019 | 382.814 | 1,61% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $735.864 | 332.970 | 1,40% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $635.702 | 287.648 | 1,21% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $607.616 | 274.820 | 1,15% | Aktien |
| GOLDMAN SACHS GROUP INC | $567.937 | 256.985 | 1,08% | Aktien |
| TWO SIGMA ADVISERS, LP | $504.678 | 216.600 | 0,96% | Aktien |
| STATE STREET CORP | $474.600 | 214.751 | 0,90% | Aktien |
| JANE STREET GROUP, LLC | $349.394 | 158.097 | 0,66% | Aktien |
| UBS Group AG | $308.693 | 139.680 | 0,59% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $253.708 | 114.800 | 0,48% | Aktien |
| NORTHERN TRUST CORP | $239.286 | 108.274 | 0,45% | Aktien |
| Point72 Asset Management, L.P. | $230.673 | 104.377 | 0,44% | Aktien |
| Ionic Capital Management LLC | $226.963 | 102.698 | 0,43% | Aktien |
| Federation des caisses Desjardins du Quebec | $202.180 | 91.900 | 0,38% | Aktien |
| Shay Capital LLC | $159.984 | 72.391 | 0,30% | Aktien |
| CITADEL ADVISORS LLC | $144.976 | 65.600 | 0,28% | Verkaufsoption |
| Invesco Ltd. | $141.981 | 64.245 | 0,27% | Aktien |
| SIMPLEX TRADING, LLC | $135.499 | 61.312 | 0,26% | Aktien |
| Verdad Advisers, LP | $113.450 | 51.335 | 0,22% | Aktien |
| XTX Topco Ltd | $111.685 | 50.536 | 0,21% | Aktien |
| JANE STREET GROUP, LLC | $104.091 | 47.100 | 0,20% | Kaufoption |
| AMERICAN CENTURY COMPANIES INC | $81.352 | 36.811 | 0,15% | Aktien |
| Cubist Systematic Strategies, LLC | $76.789 | 40.845 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76.466 | 34.600 | 0,15% | Verkaufsoption |
| AXXCESS WEALTH MANAGEMENT, LLC | $71.931 | 32.548 | 0,14% | Aktien |
| Capital Asset Advisory Services LLC | $71.931 | 32.548 | 0,14% | Aktien |
| Three Seasons Wealth, LLC | $66.300 | 30.000 | 0,13% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $63.129 | 28.565 | 0,12% | Aktien |
| JANE STREET GROUP, LLC | $59.228 | 26.800 | 0,11% | Verkaufsoption |
| Vanguard Global Advisers, LLC | $56.236 | 25.446 | 0,11% | Aktien |
| Global Retirement Partners, LLC | $55.250 | 25.000 | 0,10% | Aktien |
| OPPENHEIMER & CO INC | $50.499 | 22.850 | 0,10% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $42.649 | 19.298 | 0,08% | Aktien |
| Assenagon Asset Management S.A. | $41.186 | 18.636 | 0,08% | Aktien |
| DLK Investment Management, LLC | $40.762 | 31.355 | 0,08% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $38.958 | 17.628 | 0,07% | Aktien |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $35.570 | 16.095 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.277 | 13.700 | 0,06% | Kaufoption |
| Qube Research & Technologies Ltd | $30.153 | 13.644 | 0,06% | Aktien |
| GROUP ONE TRADING LLC | $24.020 | 10.869 | 0,05% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC ×2 Einreichungen | 16. Februar 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 10 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Esther Rajavelu | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 4. Mai 2026 S | 986.851 | 0 | 5 | $-406.848 |
| Sath Shukla | CEO & President | 5. Februar 2025 S | 1.736.883 | 0 | 0 | $0 |
| Joel Sendek | Chief Financial Officer | 2. Januar 2019 A | 15.181 | 0 | 0 | $0 |
| Timothy Keutzer | Chief Operating Officer | 6. Februar 2026 S | 742.506 | 0 | 4 | $-145.193 |
| Cristina Larkin | Chief Operating Officer | 1. Februar 2022 A | 63.581 | 0 | 0 | $0 |
| Debra Zack | Chief Medical Officer | 3. August 2026 A | 162.311 | 0 | 0 | $0 |
| Kamal Hamed | Chief Medical Officer | 2. Februar 2024 S | 788.117 | 0 | 0 | $0 |
| Tamara L Joseph | Chief Legal Officer | 2. Februar 2024 S | 531.615 | 0 | 0 | $0 |
| David A. Melnick | Chief Medical Officer | 1. Februar 2022 A | 62.081 | 0 | 0 | $0 |
| Thomas R Parr JR | Chief Scientific Officer | 2. Januar 2019 A | · | 0 | 0 | $0 |
| Kathleen Tregoning | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Cynthia Smith | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Scott Thomas Jackson | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Patrick V.J.J. Vink | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Milind Deshpande | Direktor | 23. Juni 2026 A | 101.454 | 0 | 0 | $0 |
| John C Pottage Jr | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Frank E Thomas | Direktor | 23. Juni 2026 A | 85.000 | 0 | 0 | $0 |
| Ankit Mahadevia | Direktor | 28. August 2025 S | 703.294 | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direktor | 17. August 2021 A | 2.408.128 | 0 | 0 | $0 |
| Casper Breum | Direktor | 5. Juni 2018 A | 1.091.774 | 0 | 0 | $0 |
| David P Southwell | Direktor | 5. Juni 2018 A | · | 0 | 0 | $0 |
| Vikas Goyal | Direktor | 6. November 2017 C | 1.854.006 | 0 | 0 | $0 |
| GSK plc | 10%-Eigentümer | 17. Juli 2018 P | 1.934.006 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 9 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 98.345 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,01% | 150.208 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 67.185 SH | 2. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 65.997 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 7.979 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 25.054 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 593.254 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.395.976 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 4.874 NS | 31. Juli 2026 | N-PORT |
SPRO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 6 Analysten
VERKAUF
Median-Ziel
$5.00
+320,2%
0 0,0%
Starker Kauf
0 0,0%
Kauf
3 50,0%
Halten
1 16,7%
Verkauf
2 33,3%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-04Mittelwert-Ziel $5.00 +320,2%
← Unter allen Zielen
Aktueller Preis $1.19
Tief$4.00
Mittelwert$5.00
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| TENX | $114M | -9.1 | · | · | -52.5% | · |
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| RNTX | · | -0.6 | · | · | · | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| XBIT | · | -1.6 | · | · | · | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026